When Chicago-area Abbott Laboratories cast its eye over IDEV Technologies, headquartered in Webster, Texas, as a possible subsidiary, the companies looked West for counsel, tapping teams from Jones Day and Cooley, respectively.
Jones Day is advising the health care giant on its $310 million acquisition of IDEV, a privately held developer of endovascular devices. The transaction, announced Monday, is expected to close by the end of the year. Also on Monday, Abbott announced that it would acquire Sunnyvale's OptiMedica, a maker of cataract lasers, for $250 million upfront and up to $150 million in milestone payments. Abbott declined to disclose legal counsel for that transaction, and representatives for OptiMedica did not respond.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
